NVAX
Novavax Inc
Price:  
7.25 
USD
Volume:  
5,562,945.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Novavax Fair Value

103.83 %
Upside

What is the fair value of Novavax?

As of 2025-05-24, the Fair Value of Novavax Inc (NVAX) is 14.78 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 7.25 USD, the upside of Novavax Inc is 103.83%.

Is Novavax a good investment?

With the market price of 7.25 USD and our fair value calculation, Novavax Inc (NVAX) is a good investment. Investing in Novavax stocks now will result in a potential gain of 103.83%.

7.25 USD
Stock Price
14.78 USD
Fair Price
FAIR VALUE CALCULATION

Novavax Fair Value

Peter Lynch's formula is:

Novavax Fair Value
= Earnings Growth Rate x TTM EPS
Novavax Fair Value
= 5.00 x 2.96
Novavax Fair Value
= 14.78

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31 5Y Avg
Net income -418.30 -1,743.80 -657.90 -545.06 -187.50 -710.51
YoY growth -215.22% -316.88% 62.27% 17.15% 65.60% -77.42%

Novavax Fair Value - Key Data

Market Cap (mil) 1,174.28
P/E 2.45x
Forward P/E 2.45x
EPS 2.96
Avg earnings growth rate -77.42%
TTM earnings 478.70